111 related articles for article (PubMed ID: 15831046)
1. [The study of the expression, effect and clinical relationship of TGF-beta1 CD44V6 bcl-2 and p53 in the larynx squamous carcinoma].
Huang Z; Deng H; Feng X; Zhang F; Jiang J; Liu D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):733-6. PubMed ID: 15831046
[TBL] [Abstract][Full Text] [Related]
2. [The study of the expression, effect and clinical relationship of TGF-beta 1 in the larynx squamous carcinoma].
Huang Z; Deng H; Zhang F; Jiang J; Liu D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Sep; 17(9):532-4. PubMed ID: 14658186
[TBL] [Abstract][Full Text] [Related]
3. [The relation of metastasis and prognosis with transforming growth factor-beta1 and E-cadherin expression in supraglottic larynx squamous cell carcinoma].
Zhang S; Ji W; Liu C; Yue L; Jiang Y; Wang J; Yuan Y; Liu Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jun; 20(12):534-7. PubMed ID: 16941960
[TBL] [Abstract][Full Text] [Related]
4. [The protein expression of p53 and bcl-2 in laryngeal squamous cell carcinoma].
Liu S; Tang S; Lin Y; Liang C
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):191-3. PubMed ID: 12600081
[TBL] [Abstract][Full Text] [Related]
5. [Expression of cyclooxygenase-2 and p53 and their correlation in carcinoma of larynx].
Lu H; Gong S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):421-3. PubMed ID: 15499987
[TBL] [Abstract][Full Text] [Related]
6. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
[TBL] [Abstract][Full Text] [Related]
8. [Expression of gene BRMS1 and CD44v6 protein in supraglottic laryngeal carcinoma and its clinical significance].
Guo X; Li X; Li F; Feng S; Li X; Pan Z; Guan C; Wang Y; Yang H; Jiang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 23(6):249-53. PubMed ID: 19621595
[TBL] [Abstract][Full Text] [Related]
9. [Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Yang L; Shang X; Zhao X; Lin Y; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 26(21):989-92. PubMed ID: 23373240
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma].
Qin G; Li W; Sun X; Zhu L; Chen Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Aug; 19(15):688-91. PubMed ID: 16248506
[TBL] [Abstract][Full Text] [Related]
11. [Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].
Zhang R; Song Y; Gao WJ; Zhang X; Zuo J; Lei CZ; Wang Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3341-5. PubMed ID: 20193563
[TBL] [Abstract][Full Text] [Related]
12. Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma.
Yildirim S; Cermik H; Işitmangil T; Baloglu H; Gungor A; Pekkafali Z
J Int Med Res; 2002; 30(6):597-600. PubMed ID: 12526287
[TBL] [Abstract][Full Text] [Related]
13. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
[TBL] [Abstract][Full Text] [Related]
14. [Expression of survivin and its correlation with p53 and bcl-2 expression in laryngeal and hypopharyngeal cancer].
Sun M; Qin Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Apr; 22(8):346-8, 351. PubMed ID: 18595518
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
16. Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx.
Sahoo R; Chittibabu V; Patil G; Rao S; Thakur S; Dhondalay G; Kulkarni AJ; Banerjee A; Ajaikumar BS; Korlimarla A; Nargund A; Niti RN; Gopinath KS; Prabhudesai S; Raghavendra RM
Oral Oncol; 2009 Dec; 45(12):e216-21. PubMed ID: 19729336
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of p53, Bcl-2 and Bax expression in laryngeal cancer.
Boonyaphiphat P; Pruegsanusak K; Thongsuksai P
J Med Assoc Thai; 2012 Oct; 95(10):1317-20. PubMed ID: 23193747
[TBL] [Abstract][Full Text] [Related]
18. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD44s and CD44v6 in laryngeal squamous cell carcinoma and their significance].
Wang SL; Yang Q; Xiao BK; Jiang YS; Chen EH
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 14(10):446-8. PubMed ID: 12563713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
